Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation to Manage or Treat Muscular Dystrophies.
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Muscular Dystrophies
- Sponsor
- GAAD Medical Research Institute Inc.
- Enrollment
- 4
- Locations
- 1
- Primary Endpoint
- Management and Cure of muscular dystrophies
- Last Updated
- 16 years ago
Overview
Brief Summary
The muscular dystrophies (MD) are a group of more than 30 neuromuscular disorders that are characterized by progressive skeletal muscle weakness, defects in muscle proteins and the death of muscle cells and tissue. This study will investigate the use of far infrared radiation for managing muscular dystrophies.
Detailed Description
Observations from our research studies indicate that, far infrared rays provide energy to the body, improve the autonomic functions of the nervous system, restore the functions of the endocrine system, strengthen the immune system, improve blood circulation and increase the level of oxygen in the cells and promote the regeneration of muscle cells, nerves and brain cells. It is hereby postulated that irradiation using far infrared, with wavelength between 5 to 20 microns, of the central nervous system, the endocrine system and the whole body could prevent, control, manage or possibly cure these neuromuscular disorders.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Persons with muscular dystrophies
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Management and Cure of muscular dystrophies
Time Frame: 2 Years
Secondary Outcomes
- Rehabilitation of people with muscular dystrophies(2 Years)